ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Butorphanol Tartrate Injection Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: November 2025
|
Report Code: QYRE-Auto-27I16807
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Butorphanol Tartrate Injection Market Research Report 2024
BUY CHAPTERS

Global Butorphanol Tartrate Injection Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-27I16807
Report
November 2025
Pages:144
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Dechra Veterinary
Pfizer Inc
Hospira

Butorphanol Tartrate Injection Market

The global Butorphanol Tartrate Injection market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
From a downstream perspective, Hospital accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Butorphanol Tartrate Injection leading manufacturers including Chengdu Easton Biopharmaceuticals Co.,Ltd., Jiangsu Hengrui Pharmaceuticals Co., Ltd., Fuan Pharmaceutical Group Qingyutang Pharmaceutical Co., Ltd., Sinopharm Group Co. Ltd., Hikma Pharmaceuticals USA Inc ., Dechra Veterinary, Pfizer, Hospira Inc, etc., dominate supply; the top five capture approximately % of global revenue, with Chengdu Easton Biopharmaceuticals Co.,Ltd. leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Butorphanol Tartrate Injection market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of Butorphanol Tartrate Injection Market Report

Report Metric Details
Report Name Butorphanol Tartrate Injection Market
Segment by Type
  • 1ml:1mg
  • 2ml:4mg
  • Others
Segment by Application
  • Hospital
  • Clinic
  • Others
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Chengdu Easton Biopharmaceuticals Co.,Ltd., Jiangsu Hengrui Pharmaceuticals Co., Ltd., Fuan Pharmaceutical Group Qingyutang Pharmaceutical Co., Ltd., Sinopharm Group Co. Ltd., Hikma Pharmaceuticals USA Inc ., Dechra Veterinary, Pfizer, Hospira Inc
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the Butorphanol Tartrate Injection study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
  • Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
  • Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
  • Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
  • Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
  • Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
  • Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
  • Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 15: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
  • Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the Butorphanol Tartrate Injection Market report?

Ans: The main players in the Butorphanol Tartrate Injection Market are Chengdu Easton Biopharmaceuticals Co.,Ltd., Jiangsu Hengrui Pharmaceuticals Co., Ltd., Fuan Pharmaceutical Group Qingyutang Pharmaceutical Co., Ltd., Sinopharm Group Co. Ltd., Hikma Pharmaceuticals USA Inc ., Dechra Veterinary, Pfizer, Hospira Inc

What are the Application segmentation covered in the Butorphanol Tartrate Injection Market report?

Ans: The Applications covered in the Butorphanol Tartrate Injection Market report are Hospital, Clinic, Others

What are the Type segmentation covered in the Butorphanol Tartrate Injection Market report?

Ans: The Types covered in the Butorphanol Tartrate Injection Market report are 1ml:1mg, 2ml:4mg, Others

1 Study Coverage
1.1 Introduction to Butorphanol Tartrate Injection: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Butorphanol Tartrate Injection Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 1ml:1mg
1.2.3 2ml:4mg
1.2.4 Others
1.3 Market Segmentation by Application
1.3.1 Global Butorphanol Tartrate Injection Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Butorphanol Tartrate Injection Revenue Estimates and Forecasts 2020-2031
2.2 Global Butorphanol Tartrate Injection Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Butorphanol Tartrate Injection Sales Estimates and Forecasts 2020-2031
2.4 Global Butorphanol Tartrate Injection Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Butorphanol Tartrate Injection Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Butorphanol Tartrate Injection Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 1ml:1mg Market Size by Manufacturers
3.5.2 2ml:4mg Market Size by Manufacturers
3.5.3 Others Market Size by Manufacturers
3.6 Global Butorphanol Tartrate Injection Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Butorphanol Tartrate Injection Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Butorphanol Tartrate Injection Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Butorphanol Tartrate Injection Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Butorphanol Tartrate Injection Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Butorphanol Tartrate Injection Sales and Revenue by Type (2020-2031)
6.4 North America Butorphanol Tartrate Injection Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Butorphanol Tartrate Injection Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Butorphanol Tartrate Injection Sales and Revenue by Type (2020-2031)
7.4 Europe Butorphanol Tartrate Injection Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Butorphanol Tartrate Injection Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Butorphanol Tartrate Injection Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Butorphanol Tartrate Injection Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Butorphanol Tartrate Injection Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Butorphanol Tartrate Injection Sales and Revenue by Type (2020-2031)
9.4 Central and South America Butorphanol Tartrate Injection Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Butorphanol Tartrate Injection Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Butorphanol Tartrate Injection Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Butorphanol Tartrate Injection Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Butorphanol Tartrate Injection Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Chengdu Easton Biopharmaceuticals Co.,Ltd.
11.1.1 Chengdu Easton Biopharmaceuticals Co.,Ltd. Corporation Information
11.1.2 Chengdu Easton Biopharmaceuticals Co.,Ltd. Business Overview
11.1.3 Chengdu Easton Biopharmaceuticals Co.,Ltd. Butorphanol Tartrate Injection Product Models, Descriptions and Specifications
11.1.4 Chengdu Easton Biopharmaceuticals Co.,Ltd. Butorphanol Tartrate Injection Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 Chengdu Easton Biopharmaceuticals Co.,Ltd. Butorphanol Tartrate Injection Sales by Product in 2024
11.1.6 Chengdu Easton Biopharmaceuticals Co.,Ltd. Butorphanol Tartrate Injection Sales by Application in 2024
11.1.7 Chengdu Easton Biopharmaceuticals Co.,Ltd. Butorphanol Tartrate Injection Sales by Geographic Area in 2024
11.1.8 Chengdu Easton Biopharmaceuticals Co.,Ltd. Butorphanol Tartrate Injection SWOT Analysis
11.1.9 Chengdu Easton Biopharmaceuticals Co.,Ltd. Recent Developments
11.2 Jiangsu Hengrui Pharmaceuticals Co., Ltd.
11.2.1 Jiangsu Hengrui Pharmaceuticals Co., Ltd. Corporation Information
11.2.2 Jiangsu Hengrui Pharmaceuticals Co., Ltd. Business Overview
11.2.3 Jiangsu Hengrui Pharmaceuticals Co., Ltd. Butorphanol Tartrate Injection Product Models, Descriptions and Specifications
11.2.4 Jiangsu Hengrui Pharmaceuticals Co., Ltd. Butorphanol Tartrate Injection Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 Jiangsu Hengrui Pharmaceuticals Co., Ltd. Butorphanol Tartrate Injection Sales by Product in 2024
11.2.6 Jiangsu Hengrui Pharmaceuticals Co., Ltd. Butorphanol Tartrate Injection Sales by Application in 2024
11.2.7 Jiangsu Hengrui Pharmaceuticals Co., Ltd. Butorphanol Tartrate Injection Sales by Geographic Area in 2024
11.2.8 Jiangsu Hengrui Pharmaceuticals Co., Ltd. Butorphanol Tartrate Injection SWOT Analysis
11.2.9 Jiangsu Hengrui Pharmaceuticals Co., Ltd. Recent Developments
11.3 Fuan Pharmaceutical Group Qingyutang Pharmaceutical Co., Ltd.
11.3.1 Fuan Pharmaceutical Group Qingyutang Pharmaceutical Co., Ltd. Corporation Information
11.3.2 Fuan Pharmaceutical Group Qingyutang Pharmaceutical Co., Ltd. Business Overview
11.3.3 Fuan Pharmaceutical Group Qingyutang Pharmaceutical Co., Ltd. Butorphanol Tartrate Injection Product Models, Descriptions and Specifications
11.3.4 Fuan Pharmaceutical Group Qingyutang Pharmaceutical Co., Ltd. Butorphanol Tartrate Injection Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 Fuan Pharmaceutical Group Qingyutang Pharmaceutical Co., Ltd. Butorphanol Tartrate Injection Sales by Product in 2024
11.3.6 Fuan Pharmaceutical Group Qingyutang Pharmaceutical Co., Ltd. Butorphanol Tartrate Injection Sales by Application in 2024
11.3.7 Fuan Pharmaceutical Group Qingyutang Pharmaceutical Co., Ltd. Butorphanol Tartrate Injection Sales by Geographic Area in 2024
11.3.8 Fuan Pharmaceutical Group Qingyutang Pharmaceutical Co., Ltd. Butorphanol Tartrate Injection SWOT Analysis
11.3.9 Fuan Pharmaceutical Group Qingyutang Pharmaceutical Co., Ltd. Recent Developments
11.4 Sinopharm Group Co. Ltd.
11.4.1 Sinopharm Group Co. Ltd. Corporation Information
11.4.2 Sinopharm Group Co. Ltd. Business Overview
11.4.3 Sinopharm Group Co. Ltd. Butorphanol Tartrate Injection Product Models, Descriptions and Specifications
11.4.4 Sinopharm Group Co. Ltd. Butorphanol Tartrate Injection Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 Sinopharm Group Co. Ltd. Butorphanol Tartrate Injection Sales by Product in 2024
11.4.6 Sinopharm Group Co. Ltd. Butorphanol Tartrate Injection Sales by Application in 2024
11.4.7 Sinopharm Group Co. Ltd. Butorphanol Tartrate Injection Sales by Geographic Area in 2024
11.4.8 Sinopharm Group Co. Ltd. Butorphanol Tartrate Injection SWOT Analysis
11.4.9 Sinopharm Group Co. Ltd. Recent Developments
11.5 Hikma Pharmaceuticals USA Inc .
11.5.1 Hikma Pharmaceuticals USA Inc . Corporation Information
11.5.2 Hikma Pharmaceuticals USA Inc . Business Overview
11.5.3 Hikma Pharmaceuticals USA Inc . Butorphanol Tartrate Injection Product Models, Descriptions and Specifications
11.5.4 Hikma Pharmaceuticals USA Inc . Butorphanol Tartrate Injection Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 Hikma Pharmaceuticals USA Inc . Butorphanol Tartrate Injection Sales by Product in 2024
11.5.6 Hikma Pharmaceuticals USA Inc . Butorphanol Tartrate Injection Sales by Application in 2024
11.5.7 Hikma Pharmaceuticals USA Inc . Butorphanol Tartrate Injection Sales by Geographic Area in 2024
11.5.8 Hikma Pharmaceuticals USA Inc . Butorphanol Tartrate Injection SWOT Analysis
11.5.9 Hikma Pharmaceuticals USA Inc . Recent Developments
11.6 Dechra Veterinary
11.6.1 Dechra Veterinary Corporation Information
11.6.2 Dechra Veterinary Business Overview
11.6.3 Dechra Veterinary Butorphanol Tartrate Injection Product Models, Descriptions and Specifications
11.6.4 Dechra Veterinary Butorphanol Tartrate Injection Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 Dechra Veterinary Recent Developments
11.7 Pfizer
11.7.1 Pfizer Corporation Information
11.7.2 Pfizer Business Overview
11.7.3 Pfizer Butorphanol Tartrate Injection Product Models, Descriptions and Specifications
11.7.4 Pfizer Butorphanol Tartrate Injection Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 Pfizer Recent Developments
11.8 Hospira Inc
11.8.1 Hospira Inc Corporation Information
11.8.2 Hospira Inc Business Overview
11.8.3 Hospira Inc Butorphanol Tartrate Injection Product Models, Descriptions and Specifications
11.8.4 Hospira Inc Butorphanol Tartrate Injection Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 Hospira Inc Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Butorphanol Tartrate Injection Industry Chain
12.2 Butorphanol Tartrate Injection Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Butorphanol Tartrate Injection Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Butorphanol Tartrate Injection Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Butorphanol Tartrate Injection Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Butorphanol Tartrate Injection Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
FEATURED COMPANIES
Dechra Veterinary
Pfizer Inc
Hospira
List of Tables
 Table 1. Global Butorphanol Tartrate Injection Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global Butorphanol Tartrate Injection Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global Butorphanol Tartrate Injection Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global Butorphanol Tartrate Injection Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Butorphanol Tartrate Injection Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Global Butorphanol Tartrate Injection Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)
 Table 7. Global Butorphanol Tartrate Injection Sales by Region (2020-2025) & (K Units)
 Table 8. Global Butorphanol Tartrate Injection Sales by Region (2026-2031) & (K Units)
 Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 10. Global Butorphanol Tartrate Injection Sales by Manufacturers (2020-2025) & (K Units)
 Table 11. Global Butorphanol Tartrate Injection Sales Share by Manufacturers (2020-2025)
 Table 12. Global Butorphanol Tartrate Injection Revenue by Manufacturers (2020-2025) & (US$ Million)
 Table 13. Global Butorphanol Tartrate Injection Revenue Market Share by Manufacturers (2020-2025)
 Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 15. Global Butorphanol Tartrate Injection by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Butorphanol Tartrate Injection as of 2024)
 Table 16. Global Butorphanol Tartrate Injection Average Gross Margin (%) by Manufacturer (2020 VS 2024)
 Table 17. Global Butorphanol Tartrate Injection Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
 Table 18. Key Manufacturers Butorphanol Tartrate Injection Manufacturing Base and Headquarters
 Table 19. Global Butorphanol Tartrate Injection Market Concentration Ratio (CR5 and HHI)
 Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 22. Global Butorphanol Tartrate Injection Sales by Type (2020-2025) & (K Units)
 Table 23. Global Butorphanol Tartrate Injection Sales by Type (2026-2031) & (K Units)
 Table 24. Global Butorphanol Tartrate Injection Revenue by Type (2020-2025) & (US$ Million)
 Table 25. Global Butorphanol Tartrate Injection Revenue by Type (2026-2031) & (US$ Million)
 Table 26. Global Butorphanol Tartrate Injection ASP by Type (2020-2031) & (US$/Unit)
 Table 27. Technical Specifications by Key Product Type
 Table 28. Global Butorphanol Tartrate Injection Sales by Application (2020-2025) & (K Units)
 Table 29. Global Butorphanol Tartrate Injection Sales by Application (2026-2031) & (K Units)
 Table 30. Butorphanol Tartrate Injection High-Growth Sectors Demand CAGR (2024-2031)
 Table 31. Global Butorphanol Tartrate Injection Revenue by Application (2020-2025) & (US$ Million)
 Table 32. Global Butorphanol Tartrate Injection Revenue by Application (2026-2031) & (US$ Million)
 Table 33. Global Butorphanol Tartrate Injection ASP by Application (2020-2031) & (US$/Unit)
 Table 34. Top Customers by Region
 Table 35. Top Customers by Application
 Table 36. North America Butorphanol Tartrate Injection Growth Accelerators and Market Barriers
 Table 37. North America Butorphanol Tartrate Injection Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 38. North America Butorphanol Tartrate Injection Sales (K Units) by Country (2020 VS 2024 VS 2031)
 Table 39. Europe Butorphanol Tartrate Injection Growth Accelerators and Market Barriers
 Table 40. Europe Butorphanol Tartrate Injection Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Europe Butorphanol Tartrate Injection Sales (K Units) by Country (2020 VS 2024 VS 2031)
 Table 42. Asia-Pacific Butorphanol Tartrate Injection Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 43. Asia-Pacific Butorphanol Tartrate Injection Sales (K Units) by Country (2020 VS 2024 VS 2031)
 Table 44. Asia-Pacific Butorphanol Tartrate Injection Growth Accelerators and Market Barriers
 Table 45. Southeast Asia Butorphanol Tartrate Injection Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Central and South America Butorphanol Tartrate Injection Investment Opportunities and Key Challenges
 Table 47. Central and South America Butorphanol Tartrate Injection Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 48. Middle East and Africa Butorphanol Tartrate Injection Investment Opportunities and Key Challenges
 Table 49. Middle East and Africa Butorphanol Tartrate Injection Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 50. Chengdu Easton Biopharmaceuticals Co.,Ltd. Corporation Information
 Table 51. Chengdu Easton Biopharmaceuticals Co.,Ltd. Description and Major Businesses
 Table 52. Chengdu Easton Biopharmaceuticals Co.,Ltd. Product Models, Descriptions and Specifications
 Table 53. Chengdu Easton Biopharmaceuticals Co.,Ltd. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 54. Chengdu Easton Biopharmaceuticals Co.,Ltd. Sales Value Proportion by Product in 2024
 Table 55. Chengdu Easton Biopharmaceuticals Co.,Ltd. Sales Value Proportion by Application in 2024
 Table 56. Chengdu Easton Biopharmaceuticals Co.,Ltd. Sales Value Proportion by Geographic Area in 2024
 Table 57. Chengdu Easton Biopharmaceuticals Co.,Ltd. Butorphanol Tartrate Injection SWOT Analysis
 Table 58. Chengdu Easton Biopharmaceuticals Co.,Ltd. Recent Developments
 Table 59. Jiangsu Hengrui Pharmaceuticals Co., Ltd. Corporation Information
 Table 60. Jiangsu Hengrui Pharmaceuticals Co., Ltd. Description and Major Businesses
 Table 61. Jiangsu Hengrui Pharmaceuticals Co., Ltd. Product Models, Descriptions and Specifications
 Table 62. Jiangsu Hengrui Pharmaceuticals Co., Ltd. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 63. Jiangsu Hengrui Pharmaceuticals Co., Ltd. Sales Value Proportion by Product in 2024
 Table 64. Jiangsu Hengrui Pharmaceuticals Co., Ltd. Sales Value Proportion by Application in 2024
 Table 65. Jiangsu Hengrui Pharmaceuticals Co., Ltd. Sales Value Proportion by Geographic Area in 2024
 Table 66. Jiangsu Hengrui Pharmaceuticals Co., Ltd. Butorphanol Tartrate Injection SWOT Analysis
 Table 67. Jiangsu Hengrui Pharmaceuticals Co., Ltd. Recent Developments
 Table 68. Fuan Pharmaceutical Group Qingyutang Pharmaceutical Co., Ltd. Corporation Information
 Table 69. Fuan Pharmaceutical Group Qingyutang Pharmaceutical Co., Ltd. Description and Major Businesses
 Table 70. Fuan Pharmaceutical Group Qingyutang Pharmaceutical Co., Ltd. Product Models, Descriptions and Specifications
 Table 71. Fuan Pharmaceutical Group Qingyutang Pharmaceutical Co., Ltd. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 72. Fuan Pharmaceutical Group Qingyutang Pharmaceutical Co., Ltd. Sales Value Proportion by Product in 2024
 Table 73. Fuan Pharmaceutical Group Qingyutang Pharmaceutical Co., Ltd. Sales Value Proportion by Application in 2024
 Table 74. Fuan Pharmaceutical Group Qingyutang Pharmaceutical Co., Ltd. Sales Value Proportion by Geographic Area in 2024
 Table 75. Fuan Pharmaceutical Group Qingyutang Pharmaceutical Co., Ltd. Butorphanol Tartrate Injection SWOT Analysis
 Table 76. Fuan Pharmaceutical Group Qingyutang Pharmaceutical Co., Ltd. Recent Developments
 Table 77. Sinopharm Group Co. Ltd. Corporation Information
 Table 78. Sinopharm Group Co. Ltd. Description and Major Businesses
 Table 79. Sinopharm Group Co. Ltd. Product Models, Descriptions and Specifications
 Table 80. Sinopharm Group Co. Ltd. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 81. Sinopharm Group Co. Ltd. Sales Value Proportion by Product in 2024
 Table 82. Sinopharm Group Co. Ltd. Sales Value Proportion by Application in 2024
 Table 83. Sinopharm Group Co. Ltd. Sales Value Proportion by Geographic Area in 2024
 Table 84. Sinopharm Group Co. Ltd. Butorphanol Tartrate Injection SWOT Analysis
 Table 85. Sinopharm Group Co. Ltd. Recent Developments
 Table 86. Hikma Pharmaceuticals USA Inc . Corporation Information
 Table 87. Hikma Pharmaceuticals USA Inc . Description and Major Businesses
 Table 88. Hikma Pharmaceuticals USA Inc . Product Models, Descriptions and Specifications
 Table 89. Hikma Pharmaceuticals USA Inc . Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 90. Hikma Pharmaceuticals USA Inc . Sales Value Proportion by Product in 2024
 Table 91. Hikma Pharmaceuticals USA Inc . Sales Value Proportion by Application in 2024
 Table 92. Hikma Pharmaceuticals USA Inc . Sales Value Proportion by Geographic Area in 2024
 Table 93. Hikma Pharmaceuticals USA Inc . Butorphanol Tartrate Injection SWOT Analysis
 Table 94. Hikma Pharmaceuticals USA Inc . Recent Developments
 Table 95. Dechra Veterinary Corporation Information
 Table 96. Dechra Veterinary Description and Major Businesses
 Table 97. Dechra Veterinary Product Models, Descriptions and Specifications
 Table 98. Dechra Veterinary Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 99. Dechra Veterinary Recent Developments
 Table 100. Pfizer Corporation Information
 Table 101. Pfizer Description and Major Businesses
 Table 102. Pfizer Product Models, Descriptions and Specifications
 Table 103. Pfizer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 104. Pfizer Recent Developments
 Table 105. Hospira Inc Corporation Information
 Table 106. Hospira Inc Description and Major Businesses
 Table 107. Hospira Inc Product Models, Descriptions and Specifications
 Table 108. Hospira Inc Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 109. Hospira Inc Recent Developments
 Table 110. Key Raw Materials Distribution
 Table 111. Raw Materials Key Suppliers
 Table 112. Critical Raw Material Supplier Concentration (2024) & Risk Index
 Table 113. Milestones in Production Technology Evolution
 Table 114. Distributors List
 Table 115. Market Trends and Market Evolution
 Table 116. Market Drivers and Opportunities
 Table 117. Market Challenges, Risks, and Restraints
 Table 118. Research Programs/Design for This Report
 Table 119. Key Data Information from Secondary Sources
 Table 120. Key Data Information from Primary Sources


List of Figures
 Figure 1. Butorphanol Tartrate Injection Product Picture
 Figure 2. Global Butorphanol Tartrate Injection Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. 1ml:1mg Product Picture
 Figure 4. 2ml:4mg Product Picture
 Figure 5. Others Product Picture
 Figure 6. Global Butorphanol Tartrate Injection Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 7. Hospital
 Figure 8. Clinic
 Figure 9. Others
 Figure 10. Butorphanol Tartrate Injection Report Years Considered
 Figure 11. Global Butorphanol Tartrate Injection Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Butorphanol Tartrate Injection Revenue (2020-2031) & (US$ Million)
 Figure 13. Global Butorphanol Tartrate Injection Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 14. Global Butorphanol Tartrate Injection Revenue Market Share by Region (2020-2031)
 Figure 15. Global Butorphanol Tartrate Injection Sales (2020-2031) & (K Units)
 Figure 16. Global Butorphanol Tartrate Injection Sales (CAGR) by Region (2020-2031) (K Units)
 Figure 17. Global Butorphanol Tartrate Injection Sales Market Share by Region (2020-2031)
 Figure 18. Top 5 and Top 10 Manufacturers Butorphanol Tartrate Injection Sales Volume Market Share in 2024
 Figure 19. Global Butorphanol Tartrate Injection Revenue Market Share Ranking (2024)
 Figure 20. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 21. 1ml:1mg Revenue Market Share by Manufacturer in 2024
 Figure 22. 2ml:4mg Revenue Market Share by Manufacturer in 2024
 Figure 23. Others Revenue Market Share by Manufacturer in 2024
 Figure 24. Global Butorphanol Tartrate Injection Sales Market Share by Type (2020-2031)
 Figure 25. Global Butorphanol Tartrate Injection Revenue Market Share by Type (2020-2031)
 Figure 26. Global Butorphanol Tartrate Injection Sales Market Share by Application (2020-2031)
 Figure 27. Global Butorphanol Tartrate Injection Revenue Market Share by Application (2020-2031)
 Figure 28. North America Butorphanol Tartrate Injection Sales YoY (2020-2031) & (K Units)
 Figure 29. North America Butorphanol Tartrate Injection Revenue YoY (2020-2031) & (US$ Million)
 Figure 30. North America Top 5 Manufacturers Butorphanol Tartrate Injection Sales Revenue (US$ Million) in 2024
 Figure 31. North America Butorphanol Tartrate Injection Sales Volume (K Units) by Type (2020- 2031)
 Figure 32. North America Butorphanol Tartrate Injection Sales Revenue (US$ Million) by Type (2020 - 2031)
 Figure 33. North America Butorphanol Tartrate Injection Sales Volume (K Units) by Application (2020-2031)
 Figure 34. North America Butorphanol Tartrate Injection Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 35. US Butorphanol Tartrate Injection Revenue (2020-2031) & (US$ Million)
 Figure 36. Canada Butorphanol Tartrate Injection Revenue (2020-2031) & (US$ Million)
 Figure 37. Mexico Butorphanol Tartrate Injection Revenue (2020-2031) & (US$ Million)
 Figure 38. Europe Butorphanol Tartrate Injection Sales YoY (2020-2031) & (K Units)
 Figure 39. Europe Butorphanol Tartrate Injection Revenue YoY (2020-2031) & (US$ Million)
 Figure 40. Europe Top 5 Manufacturers Butorphanol Tartrate Injection Sales Revenue (US$ Million) in 2024
 Figure 41. Europe Butorphanol Tartrate Injection Sales Volume (K Units) by Type (2020-2031)
 Figure 42. Europe Butorphanol Tartrate Injection Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 43. Europe Butorphanol Tartrate Injection Sales Volume (K Units) by Application (2020-2031)
 Figure 44. Europe Butorphanol Tartrate Injection Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 45. Germany Butorphanol Tartrate Injection Revenue (2020-2031) & (US$ Million)
 Figure 46. France Butorphanol Tartrate Injection Revenue (2020-2031) & (US$ Million)
 Figure 47. U.K. Butorphanol Tartrate Injection Revenue (2020-2031) & (US$ Million)
 Figure 48. Italy Butorphanol Tartrate Injection Revenue (2020-2031) & (US$ Million)
 Figure 49. Russia Butorphanol Tartrate Injection Revenue (2020-2031) & (US$ Million)
 Figure 50. Asia-Pacific Butorphanol Tartrate Injection Sales YoY (2020-2031) & (K Units)
 Figure 51. Asia-Pacific Butorphanol Tartrate Injection Revenue YoY (2020-2031) & (US$ Million)
 Figure 52. Asia-Pacific Top 8 Manufacturers Butorphanol Tartrate Injection Sales Revenue (US$ Million) in 2024
 Figure 53. Asia-Pacific Butorphanol Tartrate Injection Sales Volume (K Units) by Type (2020- 2031)
 Figure 54. Asia-Pacific Butorphanol Tartrate Injection Sales Revenue (US$ Million) by Type (2020- 2031)
 Figure 55. Asia-Pacific Butorphanol Tartrate Injection Sales Volume (K Units) by Application (2020-2031)
 Figure 56. Asia-Pacific Butorphanol Tartrate Injection Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 57. Indonesia Butorphanol Tartrate Injection Revenue (2020-2031) & (US$ Million)
 Figure 58. Japan Butorphanol Tartrate Injection Revenue (2020-2031) & (US$ Million)
 Figure 59. South Korea Butorphanol Tartrate Injection Revenue (2020-2031) & (US$ Million)
 Figure 60. China Taiwan Butorphanol Tartrate Injection Revenue (2020-2031) & (US$ Million)
 Figure 61. India Butorphanol Tartrate Injection Revenue (2020-2031) & (US$ Million)
 Figure 62. Central and South America Butorphanol Tartrate Injection Sales YoY (2020-2031) & (K Units)
 Figure 63. Central and South America Butorphanol Tartrate Injection Revenue YoY (2020-2031) & (US$ Million)
 Figure 64. Central and South America Top 5 Manufacturers Butorphanol Tartrate Injection Sales Revenue (US$ Million) in 2024
 Figure 65. Central and South America Butorphanol Tartrate Injection Sales Volume (K Units) by Type (2021-2031)
 Figure 66. Central and South America Butorphanol Tartrate Injection Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 67. Central and South America Butorphanol Tartrate Injection Sales Volume (K Units) by Application (2020-2031)
 Figure 68. Central and South America Butorphanol Tartrate Injection Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 69. Brazil Butorphanol Tartrate Injection Revenue (2020-2025) & (US$ Million)
 Figure 70. Argentina Butorphanol Tartrate Injection Revenue (2020-2025) & (US$ Million)
 Figure 71. Middle East, and Africa Butorphanol Tartrate Injection Sales YoY (2020-2031) & (K Units)
 Figure 72. Middle East and Africa Butorphanol Tartrate Injection Revenue YoY (2020-2031) & (US$ Million)
 Figure 73. Middle East and Africa Top 5 Manufacturers Butorphanol Tartrate Injection Sales Revenue (US$ Million) in 2024
 Figure 74. Middle East and Africa Butorphanol Tartrate Injection Sales Volume (K Units) by Type (2021-2031)
 Figure 75. South America Butorphanol Tartrate Injection Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 76. Middle East and Africa Butorphanol Tartrate Injection Sales Volume (K Units) by Application (2020-2031)
 Figure 77. Middle East and Africa Butorphanol Tartrate Injection Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 78. GCC Countries Butorphanol Tartrate Injection Revenue (2020-2025) & (US$ Million)
 Figure 79. Turkey Butorphanol Tartrate Injection Revenue (2020-2025) & (US$ Million)
 Figure 80. Egypt Butorphanol Tartrate Injection Revenue (2020-2025) & (US$ Million)
 Figure 81. South Africa Butorphanol Tartrate Injection Revenue (2020-2025) & (US$ Million)
 Figure 82. Butorphanol Tartrate Injection Industry Chain Mapping
 Figure 83. Regional Butorphanol Tartrate Injection Manufacturing Base Distribution (%)
 Figure 84. Global Butorphanol Tartrate Injection Production Market Share by Region (2020-2031)
 Figure 85. Butorphanol Tartrate Injection Production Process
 Figure 86. Regional Butorphanol Tartrate Injection Production Cost Structure
 Figure 87. Channels of Distribution (Direct Vs Distribution)
 Figure 88. Bottom-up and Top-down Approaches for This Report
 Figure 89. Data Triangulation
 Figure 90. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS

Global Metoprolol Tartrate Injection Market Research Report 2024
Global Stearyl Tartrate Market Research Report 2024
Global Gadobutrol Injection Market Research Report 2024
Global Butyl Propionate Market Research Report 2024
Global Ammonium Tartrate Market Research Report 2025
Terbutaline Sulfate Injection Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Arformoterol Tartrate API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Tolterodine Tartrate API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Caffeine Citrate Injection Market Research Report 2024
Global Tylosin Tartrate API Market Research Report 2025
Global Troxerutin for Injection Market Research Report 2024
Global Tert butyl Acetate Market Research Report 2025
Global Atropine Sulfate Injection Market Research Report 2024
Global Aprepitant Injection Market Research Report 2025
Global Morphine Sulfate Injection Market Research Report 2024
Global Salbutamol Injection Market Research Report 2024
Global Butamirate Citrate Market Research Report 2024
Global Potassium Tartrate Market Research Report 2025
Global Cetrorelix Acetate for Injection Market Research Report 2024
Global Desmopressin Acetate Injection Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions